Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dianthus Therapeutics (DNTH) Interest & Investment Income: 2017-2024

Historic Interest & Investment Income for Dianthus Therapeutics (DNTH) over the last 6 years, with Dec 2024 value amounting to $17.4 million.

  • Dianthus Therapeutics' Interest & Investment Income fell 17.71% to $3.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.8 million, marking a year-over-year decrease of 6.18%. This contributed to the annual value of $17.4 million for FY2024, which is 264.50% up from last year.
  • Latest data reveals that Dianthus Therapeutics reported Interest & Investment Income of $17.4 million as of FY2024, which was up 264.50% from $4.8 million recorded in FY2023.
  • In the past 5 years, Dianthus Therapeutics' Interest & Investment Income registered a high of $17.4 million during FY2024, and its lowest value of $1.1 million during FY2022.
  • In the last 3 years, Dianthus Therapeutics' Interest & Investment Income had a median value of $4.8 million in 2023 and averaged $7.8 million.
  • Data for Dianthus Therapeutics' Interest & Investment Income shows a peak YoY skyrocketed of 316.07% (in 2023) over the last 5 years.
  • Dianthus Therapeutics' Interest & Investment Income (Yearly) stood at $1.1 million in 2022, then spiked by 316.07% to $4.8 million in 2023, then skyrocketed by 264.50% to $17.4 million in 2024.